Korea Has 35 Million Doses of Monkeypox Vaccine

Korea is well prepared if monkeypox spreads here, though another pandemic of coronavirus proportions seems extremely unlikely.

Korea already has 35 million doses of second-generation monkeypox vaccines in case the disease should spread here. But a third-generation vaccine called Imbanex, developed by Bavarian Nordic of Denmark and causing fewer side effects than earlier versions, is not available here yet.

The second-generation vaccine must be administered within 14 days of suspected exposure to the virus.

A monkeypox treatment called Tecovirimat has also been developed by SIGA Technologies of the U.S. The government said it is in talks to bring in 5 million doses next month.